Screener
CorMedix CRMD Income Tax Reconciliation Foreign Income Tax Rate Differential
Income Tax Reconciliation Foreign Income Tax Rate Differential at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential.
The source filing: CorMedix’s 10-K, filed March 5, 2026.
- Filed
- Mar 5, 2026, 8:32 AM EST
- Fiscal year
- FY2025
- Accession
- 0001213900-26-023889
| Line item | 2025 / Amount | 2025 / Percent | 2024 / Amount | 2024 / Percent |
|---|---|---|---|---|
| U.S. federal statutory tax rate | $31,503 | 21.0% | $(4,058) | 21.0% |
| State and local income tax (net of federal) (a) | 10,367 | 6.9% | (1,395) | 7.2% |
| Foreign tax effects | - | 0.0% | 57 | (0.3 |
| Effects of changes in tax laws or rates enacted in the current period | - | 0.0% | - | 0.0% |
| Changes in valuation allowances: | (60,713) | (40.5 | 675 | (3.5 |
| Non-taxable or non-deductible items | ||||
| Stock compensation | (851) | (0.6 | 1,473 | (7.6 |
| Transaction Cost | 2,122 | 1.4% | - | 0.0% |
Item 16. Form 10-K Summary
FAQ
- What is CorMedix's income tax reconciliation foreign income tax rate differential?
- CorMedix (CRMD) reported income tax reconciliation foreign income tax rate differential of $14.25K in Q4 2024.
- What does income tax reconciliation foreign income tax rate differential mean?
- Reflects the specific tax effects arising from foreign operations, including adjustments for foreign tax rates that differ from the domestic statutory rate. This metric helps isolate the tax impact of international expansion and global revenue generation. Investors use it to evaluate the tax-related risks and benefits of operating in multiple countries.
Ask your AI about CorMedix's income tax reconciliation foreign income tax rate differential.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude